Clinical Trial Update: Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment

View source ↗

Summary

This clinical trial assesses the expression of Cadherin 6 (CDH6) in primary malignant bone tumors and investigates its potential use for prognosis assessment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Osteosarcoma
• Sarcoma

Snippet

Sponsor: Peking University People's Hospital | Conditions: Sarcoma, Sarcoma, Bone | Status: ACTIVE_NOT_RECRUITING